101 to News@lemmy.worldEnglish · 14 hours agoSEC Charges Cassava Sciences, Two Former Executives for Misleading Claims About Alzheimer’s Clinical Trial.www.sec.govexternal-linkmessage-square0fedilinkarrow-up136arrow-down10
arrow-up136arrow-down1external-linkSEC Charges Cassava Sciences, Two Former Executives for Misleading Claims About Alzheimer’s Clinical Trial.www.sec.gov101 to News@lemmy.worldEnglish · 14 hours agomessage-square0fedilink